Shaun Curtis - Embecta Corp Senior Chain
| EMBC Stock | USD 10.13 0.31 2.97% |
Executive
Shaun Curtis is Senior Chain of Embecta Corp
| Age | 55 |
| Address | 300 Kimball Drive, Parsippany, NJ, United States, 07054 |
| Phone | 862 401 0000 |
| Web | https://www.embecta.com |
Shaun Curtis Latest Insider Activity
Tracking and analyzing the buying and selling activities of Shaun Curtis against Embecta Corp stock is an integral part of due diligence when investing in Embecta Corp. Shaun Curtis insider activity provides valuable insight into whether Embecta Corp is net buyers or sellers over its current business cycle. Note, Embecta Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Embecta Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Shaun Curtis over a year ago Payment of 920 shares by Shaun Curtis of Embecta Corp subject to Rule 16b-3 |
Embecta Corp Management Efficiency
The company has return on total asset (ROA) of 0.1021 % which means that it generated a profit of $0.1021 on every $100 spent on assets. This is way below average. Embecta Corp's management efficiency ratios could be used to measure how well Embecta Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of May 1, 2024, Return On Tangible Assets is expected to decline to 0.06. In addition to that, Return On Capital Employed is expected to decline to 0.28. At present, Embecta Corp's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 10.6 M, whereas Total Assets are forecasted to decline to about 1 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kathleen JD | HCA Holdings | 60 | |
| MD MBA | HCA Holdings | 58 | |
| Emily Mattacchione | Novo Integrated Sciences | 43 | |
| Heather CPA | Acadia Healthcare | 52 | |
| Jim Brown | HCA Holdings | N/A | |
| Isa Diaz | Acadia Healthcare | N/A | |
| Frank CFA | HCA Holdings | N/A | |
| Chad Wasserman | HCA Holdings | N/A | |
| Klara Radulyne | Novo Integrated Sciences | 38 | |
| Jeffrey Cohen | HCA Holdings | 52 | |
| Joseph III | HCA Holdings | 67 | |
| Kirk Cheney | Pennant Group | N/A | |
| Gretchen Hommrich | Acadia Healthcare | N/A | |
| Terence Arkel | HCA Holdings | N/A | |
| Lynette CPA | Pennant Group | 47 | |
| Bill Priest | Acadia Healthcare | N/A | |
| Nasser MD | Acadia Healthcare | N/A | |
| Chen Zhang | Aesthetic Medical Intl | N/A | |
| Martin Paslick | HCA Holdings | 64 | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| Laura Groschen | Acadia Healthcare | N/A | |
Management Performance
Embecta Corp Leadership Team
Elected by the shareholders, the Embecta Corp's board of directors comprises two types of representatives: Embecta Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Embecta. The board's role is to monitor Embecta Corp's management team and ensure that shareholders' interests are well served. Embecta Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Embecta Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey Mann, General VP | ||
| Jean Casner, Senior Officer | ||
| Brian Capone, Chief VP | ||
| Slobodan Radumilo, VP International | ||
| Devdatt Kurdikar, CEO President | ||
| Shaun Curtis, Senior Chain | ||
| Ginny Blocki, Senior Management | ||
| Tom Blount, Senior America | ||
| Ajay Kumar, VP Officer | ||
| Colleen Riley, Senior Officer | ||
| Pravesh Khandelwal, VP Relations | ||
| Jacob Elguicze, Senior CFO |
Embecta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Embecta Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.96 B | ||||
| Shares Outstanding | 57.58 M | ||||
| Shares Owned By Insiders | 0.46 % | ||||
| Shares Owned By Institutions | 98.74 % | ||||
| Number Of Shares Shorted | 2.54 M | ||||
| Price To Earning | 4.91 X | ||||
| Price To Book | 2.61 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Embecta Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Embecta Corp's short interest history, or implied volatility extrapolated from Embecta Corp options trading.
Pair Trading with Embecta Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Embecta Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Embecta Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with Embecta Stock
| 0.83 | AHG | Akso Health Group | PairCorr |
Moving against Embecta Stock
| 0.86 | SNDA | Sonida Senior Living | PairCorr |
| 0.85 | TNDM | Tandem Diabetes Care | PairCorr |
| 0.8 | GCTK | GlucoTrack | PairCorr |
| 0.74 | TLIS | Talis Biomedical Corp | PairCorr |
| 0.72 | JYNT | Joint Corp Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Embecta Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Embecta Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Embecta Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Embecta Corp to buy it.
The correlation of Embecta Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Embecta Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Embecta Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Embecta Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Embecta Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.Note that the Embecta Corp information on this page should be used as a complementary analysis to other Embecta Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Embecta Stock analysis
When running Embecta Corp's price analysis, check to measure Embecta Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Embecta Corp is operating at the current time. Most of Embecta Corp's value examination focuses on studying past and present price action to predict the probability of Embecta Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Embecta Corp's price. Additionally, you may evaluate how the addition of Embecta Corp to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Embecta Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.6 | Earnings Share 0.96 | Revenue Per Share 19.574 | Quarterly Revenue Growth 0.006 |
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.